Home / Inspections / 1007260

FDA Inspection 1007260 — Novo Nordisk A/S

Novo Nordisk A/S — FEI 3000151819

The FDA completed an inspection of Novo Nordisk A/S on February 8, 2017 in Bagsvard. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 8, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bagsvard (Denmark)

Facility

Other inspections at this facility

  • 1245306 (VAI Wed Mar 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1165895 (VAI Thu Dec 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1057438 (NAI Fri May 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 964462 (NAI Fri Apr 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 846713 (VAI Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources